Literature DB >> 28328630

Fluorescein Isothiocyanate: A Novel Application for Lymphatic Surgery.

Lisa Spiguel1, Christiana Shaw, Adam Katz, Lifei Guo, Hung-Chi Chen, Bernard T Lee, Dhruv Singhal.   

Abstract

The Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) procedure entails performing a lymphovenous bypass (LVB) at the time of axillary lymph node dissection to reduce lymphedema risk. The two most common fluorophores utilized in LVB are blue dye and indocyanine green. We developed a novel application of fluorescein isothiocyanate for intraoperative lymphatic mapping. Our goal is to demonstrate the safety and efficacy of fluorescein isothiocyanate for this application. We reviewed a prospectively collected database on breast cancer patients who underwent LYMPHA from March to September 2015. Fluorescein isothiocyanate was used to identify arm lymphatic channels after axillary lymph node dissection to perform an LVB between disrupted lymphatics and axillary vein tributaries. Data on preoperative and intraoperative variables were analyzed. Thirteen patients underwent LYMPHA with intraoperative fluorescein isothiocyanate lymphatic mapping from March to September 2015. Average patient age was 50 years with a mean body mass index of 28. On average, 3.4 lacerated lymphatic channels were identified at an average distance of 2.72 cm (range, 0.25-5 cm) caudal to the axillary vein. On average, 1.7 channels were bypassed per patient. Eleven anastomoses were performed to the accessory branch of the axillary vein and 1 to a lateral branch. In 1 patient, a bypass was not performed due to poor lymphatic caliber and inadequate length of the harvested vein tributary. No intraoperative adverse events were noted. Fluorescein isothiocyanate is a safe and effective method for intra-operative lymphatic mapping. Fluorescein isothiocyanate imaging allows for simultaneous dissection and lymphatic visualization, making it an ideal agent for lymphatic mapping and dissection in open surgical fields, such as in the LYMPHA procedure.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28328630     DOI: 10.1097/SAP.0000000000001034

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  5 in total

1.  Dual Fluorescent Tracers for Surgical Guidance: Preventing Donor-site Lymphedema in Vascularized Lymph Node Transfer.

Authors:  Irene A Chang; Marco A Swanson; Meenakshi Rajan; Graham S Schwarz
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-06-21

2.  Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for Lymphedema Prevention after Axillary Lymph Node Dissection-A Single Institution Experience and Feasibility of Technique.

Authors:  Kelsey Lipman; Anna Luan; Kimberly Stone; Irene Wapnir; Mardi Karin; Dung Nguyen
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

3.  A colorful approach towards developing new nano-based imaging contrast agents for improved cancer detection.

Authors:  Helen R Salinas; Dominie L Miyasato; Olga E Eremina; Rodolfo Perez; Karen L Gonzalez; Alexander T Czaja; Sean Burkitt; Arjun Aron; Augusta Fernando; Lauro S Ojeda; Kimberly N Larson; Ahmed W Mohamed; Jos L Campbell; Beth A Goins; Cristina Zavaleta
Journal:  Biomater Sci       Date:  2020-08-19       Impact factor: 6.843

4.  Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.

Authors:  Kelly M Herremans; Morgan P Cribbin; Andrea N Riner; Dan W Neal; Tracy L Hollen; Pamela Clevenger; Derly Munoz; Shannon Blewett; Fantine Giap; Paul G Okunieff; Nancy P Mendenhall; Julie A Bradley; William M Mendenhall; Raymond B Mailhot-Vega; Eric Brooks; Karen C Daily; Coy D Heldermon; Julia K Marshall; Mariam W Hanna; Mark M Leyngold; Sarah S Virk; Christiana M Shaw; Lisa R Spiguel
Journal:  Ann Surg Oncol       Date:  2021-08-07       Impact factor: 5.344

5.  A Fluorescence-Based Wireless Capsule Endoscopy System for Detecting Colorectal Cancer.

Authors:  Mohammad Wajih Alam; Seyed Shahim Vedaei; Khan A Wahid
Journal:  Cancers (Basel)       Date:  2020-04-06       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.